CANCER LETT 润色咨询

CANCER LETTERS

出版年份:1975 年文章数:4498 投稿命中率: 开通期刊会员,数据随心看

出版周期:Biweekly 自引率:3.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=562013, encodeId=6b2a56201341, content=我的6号投的,今天还是这贵状态<span class="quote"> 2018-10-12 00:00:00 发表:<br>不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧</span>, beContent= 2018-10-12 00:00:00 发表: 不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RIBJlEmicIauGBQQiaeMgwsS5uz5UatGvaxteNDIUozlgVZFghRIuuUBWSeEy1XCBdEkMK2ic21XuTl6FQGK6C5lg/132, createdBy=e6fc2342780, createdName=mei1996, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561919, encodeId=4b1356191963, content=不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧<span class="quote">maoweipu 2018-10-09 00:00:00 发表:<br>你的什么状态了,我的submitted to journal快一周了</span>, beContent=maoweipu 2018-10-09 00:00:00 发表: 你的什么状态了,我的submitted to journal快一周了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=625f1875342, createdName=ms5567750162973767, createdTime=Fri Oct 12 00:00:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561815, encodeId=43fd561815ea, content=你的什么状态了,我的submitted to journal快一周了<span class="quote">136****6975(暂无匿称) 2018-08-19 发表::<br>今天刚投,submitted to journal.忐忑中。</span><span class="quote">136****6975(暂无匿称) 2018-08-19 00:00:00 发表:<br>今天刚投,submitted to journal.忐忑中。</span>, beContent=136****6975(暂无匿称) 2018-08-19 发表:: 今天刚投,submitted to journal.忐忑中。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Tue Oct 09 00:00:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561606, encodeId=cb585616061a, content=这个杂志是要审稿费吗?<span class="quote">fatvicky 2018-08-21 00:00:00 发表:<br>你的怎么样了?我的under review11天后,现在变成under editor evaluation 了</span>, beContent=fatvicky 2018-08-21 00:00:00 发表: 你的怎么样了?我的under review11天后,现在变成under editor evaluation 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/9781858056D46BD00872513F9FF65E51/100, createdBy=df292075308, createdName=manqing, createdTime=Sun Sep 30 00:00:00 CST 2018, time=2018-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561466, encodeId=80a45614669f, content=这个接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96a82335180, createdName=1227b427m60暂无昵称, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561315, encodeId=ce2d561315ff, content=可以的<span class="quote">135****3848(暂无匿称) 2018-09-11 发表::<br>肿瘤以外的细胞周期内容接受吗</span><span class="quote">135****3848(暂无匿称) 2018-09-11 00:00:00 发表:<br>肿瘤以外的细胞周期内容接受吗</span>, beContent=135****3848(暂无匿称) 2018-09-11 发表:: 肿瘤以外的细胞周期内容接受吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561316, encodeId=1e3a561316ec, content=可以收<span class="quote">医生包子 2018-09-05 发表::<br>请问收不收临床杂志</span><span class="quote">医生包子 2018-09-05 08:42:00 发表:<br>请问收不收临床杂志</span>, beContent=医生包子 2018-09-05 发表:: 请问收不收临床杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560936, encodeId=90b656093635, content=肿瘤以外的细胞周期内容接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560739, encodeId=fee1560e39f2, content=请问收不收临床杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/10/4fe36596645bdae9591cdb5eaef8d8ad.jpg, createdBy=d0ff2244072, createdName=医生包子, createdTime=Wed Sep 05 08:42:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560615, encodeId=c0b45606157d, content=你的后来咋样了啊?<span class="quote">fatvicky 2018-08-28 发表::<br>好吧,我的变成decision in process了</span><span class="quote">fatvicky 2018-08-28 00:00:00 发表:<br>好吧,我的变成decision in process了</span>, beContent=fatvicky 2018-08-28 发表:: 好吧,我的变成decision in process了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-10-15 mei1996

    我的6号投的,今天还是这贵状态 2018-10-12 00:00:00 发表:
    不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧

    2018-10-12 00:00:00 发表: 不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=562013, encodeId=6b2a56201341, content=我的6号投的,今天还是这贵状态<span class="quote"> 2018-10-12 00:00:00 发表:<br>不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧</span>, beContent= 2018-10-12 00:00:00 发表: 不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RIBJlEmicIauGBQQiaeMgwsS5uz5UatGvaxteNDIUozlgVZFghRIuuUBWSeEy1XCBdEkMK2ic21XuTl6FQGK6C5lg/132, createdBy=e6fc2342780, createdName=mei1996, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561919, encodeId=4b1356191963, content=不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧<span class="quote">maoweipu 2018-10-09 00:00:00 发表:<br>你的什么状态了,我的submitted to journal快一周了</span>, beContent=maoweipu 2018-10-09 00:00:00 发表: 你的什么状态了,我的submitted to journal快一周了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=625f1875342, createdName=ms5567750162973767, createdTime=Fri Oct 12 00:00:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561815, encodeId=43fd561815ea, content=你的什么状态了,我的submitted to journal快一周了<span class="quote">136****6975(暂无匿称) 2018-08-19 发表::<br>今天刚投,submitted to journal.忐忑中。</span><span class="quote">136****6975(暂无匿称) 2018-08-19 00:00:00 发表:<br>今天刚投,submitted to journal.忐忑中。</span>, beContent=136****6975(暂无匿称) 2018-08-19 发表:: 今天刚投,submitted to journal.忐忑中。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Tue Oct 09 00:00:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561606, encodeId=cb585616061a, content=这个杂志是要审稿费吗?<span class="quote">fatvicky 2018-08-21 00:00:00 发表:<br>你的怎么样了?我的under review11天后,现在变成under editor evaluation 了</span>, beContent=fatvicky 2018-08-21 00:00:00 发表: 你的怎么样了?我的under review11天后,现在变成under editor evaluation 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/9781858056D46BD00872513F9FF65E51/100, createdBy=df292075308, createdName=manqing, createdTime=Sun Sep 30 00:00:00 CST 2018, time=2018-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561466, encodeId=80a45614669f, content=这个接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96a82335180, createdName=1227b427m60暂无昵称, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561315, encodeId=ce2d561315ff, content=可以的<span class="quote">135****3848(暂无匿称) 2018-09-11 发表::<br>肿瘤以外的细胞周期内容接受吗</span><span class="quote">135****3848(暂无匿称) 2018-09-11 00:00:00 发表:<br>肿瘤以外的细胞周期内容接受吗</span>, beContent=135****3848(暂无匿称) 2018-09-11 发表:: 肿瘤以外的细胞周期内容接受吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561316, encodeId=1e3a561316ec, content=可以收<span class="quote">医生包子 2018-09-05 发表::<br>请问收不收临床杂志</span><span class="quote">医生包子 2018-09-05 08:42:00 发表:<br>请问收不收临床杂志</span>, beContent=医生包子 2018-09-05 发表:: 请问收不收临床杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560936, encodeId=90b656093635, content=肿瘤以外的细胞周期内容接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560739, encodeId=fee1560e39f2, content=请问收不收临床杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/10/4fe36596645bdae9591cdb5eaef8d8ad.jpg, createdBy=d0ff2244072, createdName=医生包子, createdTime=Wed Sep 05 08:42:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560615, encodeId=c0b45606157d, content=你的后来咋样了啊?<span class="quote">fatvicky 2018-08-28 发表::<br>好吧,我的变成decision in process了</span><span class="quote">fatvicky 2018-08-28 00:00:00 发表:<br>好吧,我的变成decision in process了</span>, beContent=fatvicky 2018-08-28 发表:: 好吧,我的变成decision in process了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-10-12 ms5567750162973767

    不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧maoweipu 2018-10-09 00:00:00 发表:
    你的什么状态了,我的submitted to journal快一周了

    maoweipu 2018-10-09 00:00:00 发表: 你的什么状态了,我的submitted to journal快一周了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=562013, encodeId=6b2a56201341, content=我的6号投的,今天还是这贵状态<span class="quote"> 2018-10-12 00:00:00 发表:<br>不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧</span>, beContent= 2018-10-12 00:00:00 发表: 不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RIBJlEmicIauGBQQiaeMgwsS5uz5UatGvaxteNDIUozlgVZFghRIuuUBWSeEy1XCBdEkMK2ic21XuTl6FQGK6C5lg/132, createdBy=e6fc2342780, createdName=mei1996, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561919, encodeId=4b1356191963, content=不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧<span class="quote">maoweipu 2018-10-09 00:00:00 发表:<br>你的什么状态了,我的submitted to journal快一周了</span>, beContent=maoweipu 2018-10-09 00:00:00 发表: 你的什么状态了,我的submitted to journal快一周了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=625f1875342, createdName=ms5567750162973767, createdTime=Fri Oct 12 00:00:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561815, encodeId=43fd561815ea, content=你的什么状态了,我的submitted to journal快一周了<span class="quote">136****6975(暂无匿称) 2018-08-19 发表::<br>今天刚投,submitted to journal.忐忑中。</span><span class="quote">136****6975(暂无匿称) 2018-08-19 00:00:00 发表:<br>今天刚投,submitted to journal.忐忑中。</span>, beContent=136****6975(暂无匿称) 2018-08-19 发表:: 今天刚投,submitted to journal.忐忑中。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Tue Oct 09 00:00:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561606, encodeId=cb585616061a, content=这个杂志是要审稿费吗?<span class="quote">fatvicky 2018-08-21 00:00:00 发表:<br>你的怎么样了?我的under review11天后,现在变成under editor evaluation 了</span>, beContent=fatvicky 2018-08-21 00:00:00 发表: 你的怎么样了?我的under review11天后,现在变成under editor evaluation 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/9781858056D46BD00872513F9FF65E51/100, createdBy=df292075308, createdName=manqing, createdTime=Sun Sep 30 00:00:00 CST 2018, time=2018-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561466, encodeId=80a45614669f, content=这个接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96a82335180, createdName=1227b427m60暂无昵称, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561315, encodeId=ce2d561315ff, content=可以的<span class="quote">135****3848(暂无匿称) 2018-09-11 发表::<br>肿瘤以外的细胞周期内容接受吗</span><span class="quote">135****3848(暂无匿称) 2018-09-11 00:00:00 发表:<br>肿瘤以外的细胞周期内容接受吗</span>, beContent=135****3848(暂无匿称) 2018-09-11 发表:: 肿瘤以外的细胞周期内容接受吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561316, encodeId=1e3a561316ec, content=可以收<span class="quote">医生包子 2018-09-05 发表::<br>请问收不收临床杂志</span><span class="quote">医生包子 2018-09-05 08:42:00 发表:<br>请问收不收临床杂志</span>, beContent=医生包子 2018-09-05 发表:: 请问收不收临床杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560936, encodeId=90b656093635, content=肿瘤以外的细胞周期内容接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560739, encodeId=fee1560e39f2, content=请问收不收临床杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/10/4fe36596645bdae9591cdb5eaef8d8ad.jpg, createdBy=d0ff2244072, createdName=医生包子, createdTime=Wed Sep 05 08:42:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560615, encodeId=c0b45606157d, content=你的后来咋样了啊?<span class="quote">fatvicky 2018-08-28 发表::<br>好吧,我的变成decision in process了</span><span class="quote">fatvicky 2018-08-28 00:00:00 发表:<br>好吧,我的变成decision in process了</span>, beContent=fatvicky 2018-08-28 发表:: 好吧,我的变成decision in process了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-10-09 maoweipu

    你的什么状态了,我的submitted to journal快一周了136****6975(暂无匿称) 2018-08-19 发表::
    今天刚投,submitted to journal.忐忑中。
    136****6975(暂无匿称) 2018-08-19 00:00:00 发表:
    今天刚投,submitted to journal.忐忑中。

    136****6975(暂无匿称) 2018-08-19 发表:: 今天刚投,submitted to journal.忐忑中。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=562013, encodeId=6b2a56201341, content=我的6号投的,今天还是这贵状态<span class="quote"> 2018-10-12 00:00:00 发表:<br>不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧</span>, beContent= 2018-10-12 00:00:00 发表: 不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RIBJlEmicIauGBQQiaeMgwsS5uz5UatGvaxteNDIUozlgVZFghRIuuUBWSeEy1XCBdEkMK2ic21XuTl6FQGK6C5lg/132, createdBy=e6fc2342780, createdName=mei1996, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561919, encodeId=4b1356191963, content=不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧<span class="quote">maoweipu 2018-10-09 00:00:00 发表:<br>你的什么状态了,我的submitted to journal快一周了</span>, beContent=maoweipu 2018-10-09 00:00:00 发表: 你的什么状态了,我的submitted to journal快一周了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=625f1875342, createdName=ms5567750162973767, createdTime=Fri Oct 12 00:00:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561815, encodeId=43fd561815ea, content=你的什么状态了,我的submitted to journal快一周了<span class="quote">136****6975(暂无匿称) 2018-08-19 发表::<br>今天刚投,submitted to journal.忐忑中。</span><span class="quote">136****6975(暂无匿称) 2018-08-19 00:00:00 发表:<br>今天刚投,submitted to journal.忐忑中。</span>, beContent=136****6975(暂无匿称) 2018-08-19 发表:: 今天刚投,submitted to journal.忐忑中。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Tue Oct 09 00:00:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561606, encodeId=cb585616061a, content=这个杂志是要审稿费吗?<span class="quote">fatvicky 2018-08-21 00:00:00 发表:<br>你的怎么样了?我的under review11天后,现在变成under editor evaluation 了</span>, beContent=fatvicky 2018-08-21 00:00:00 发表: 你的怎么样了?我的under review11天后,现在变成under editor evaluation 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/9781858056D46BD00872513F9FF65E51/100, createdBy=df292075308, createdName=manqing, createdTime=Sun Sep 30 00:00:00 CST 2018, time=2018-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561466, encodeId=80a45614669f, content=这个接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96a82335180, createdName=1227b427m60暂无昵称, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561315, encodeId=ce2d561315ff, content=可以的<span class="quote">135****3848(暂无匿称) 2018-09-11 发表::<br>肿瘤以外的细胞周期内容接受吗</span><span class="quote">135****3848(暂无匿称) 2018-09-11 00:00:00 发表:<br>肿瘤以外的细胞周期内容接受吗</span>, beContent=135****3848(暂无匿称) 2018-09-11 发表:: 肿瘤以外的细胞周期内容接受吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561316, encodeId=1e3a561316ec, content=可以收<span class="quote">医生包子 2018-09-05 发表::<br>请问收不收临床杂志</span><span class="quote">医生包子 2018-09-05 08:42:00 发表:<br>请问收不收临床杂志</span>, beContent=医生包子 2018-09-05 发表:: 请问收不收临床杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560936, encodeId=90b656093635, content=肿瘤以外的细胞周期内容接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560739, encodeId=fee1560e39f2, content=请问收不收临床杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/10/4fe36596645bdae9591cdb5eaef8d8ad.jpg, createdBy=d0ff2244072, createdName=医生包子, createdTime=Wed Sep 05 08:42:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560615, encodeId=c0b45606157d, content=你的后来咋样了啊?<span class="quote">fatvicky 2018-08-28 发表::<br>好吧,我的变成decision in process了</span><span class="quote">fatvicky 2018-08-28 00:00:00 发表:<br>好吧,我的变成decision in process了</span>, beContent=fatvicky 2018-08-28 发表:: 好吧,我的变成decision in process了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-30 manqing

    这个杂志是要审稿费吗?fatvicky 2018-08-21 00:00:00 发表:
    你的怎么样了?我的under review11天后,现在变成under editor evaluation 了

    fatvicky 2018-08-21 00:00:00 发表: 你的怎么样了?我的under review11天后,现在变成under editor evaluation 了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=562013, encodeId=6b2a56201341, content=我的6号投的,今天还是这贵状态<span class="quote"> 2018-10-12 00:00:00 发表:<br>不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧</span>, beContent= 2018-10-12 00:00:00 发表: 不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RIBJlEmicIauGBQQiaeMgwsS5uz5UatGvaxteNDIUozlgVZFghRIuuUBWSeEy1XCBdEkMK2ic21XuTl6FQGK6C5lg/132, createdBy=e6fc2342780, createdName=mei1996, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561919, encodeId=4b1356191963, content=不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧<span class="quote">maoweipu 2018-10-09 00:00:00 发表:<br>你的什么状态了,我的submitted to journal快一周了</span>, beContent=maoweipu 2018-10-09 00:00:00 发表: 你的什么状态了,我的submitted to journal快一周了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=625f1875342, createdName=ms5567750162973767, createdTime=Fri Oct 12 00:00:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561815, encodeId=43fd561815ea, content=你的什么状态了,我的submitted to journal快一周了<span class="quote">136****6975(暂无匿称) 2018-08-19 发表::<br>今天刚投,submitted to journal.忐忑中。</span><span class="quote">136****6975(暂无匿称) 2018-08-19 00:00:00 发表:<br>今天刚投,submitted to journal.忐忑中。</span>, beContent=136****6975(暂无匿称) 2018-08-19 发表:: 今天刚投,submitted to journal.忐忑中。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Tue Oct 09 00:00:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561606, encodeId=cb585616061a, content=这个杂志是要审稿费吗?<span class="quote">fatvicky 2018-08-21 00:00:00 发表:<br>你的怎么样了?我的under review11天后,现在变成under editor evaluation 了</span>, beContent=fatvicky 2018-08-21 00:00:00 发表: 你的怎么样了?我的under review11天后,现在变成under editor evaluation 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/9781858056D46BD00872513F9FF65E51/100, createdBy=df292075308, createdName=manqing, createdTime=Sun Sep 30 00:00:00 CST 2018, time=2018-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561466, encodeId=80a45614669f, content=这个接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96a82335180, createdName=1227b427m60暂无昵称, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561315, encodeId=ce2d561315ff, content=可以的<span class="quote">135****3848(暂无匿称) 2018-09-11 发表::<br>肿瘤以外的细胞周期内容接受吗</span><span class="quote">135****3848(暂无匿称) 2018-09-11 00:00:00 发表:<br>肿瘤以外的细胞周期内容接受吗</span>, beContent=135****3848(暂无匿称) 2018-09-11 发表:: 肿瘤以外的细胞周期内容接受吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561316, encodeId=1e3a561316ec, content=可以收<span class="quote">医生包子 2018-09-05 发表::<br>请问收不收临床杂志</span><span class="quote">医生包子 2018-09-05 08:42:00 发表:<br>请问收不收临床杂志</span>, beContent=医生包子 2018-09-05 发表:: 请问收不收临床杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560936, encodeId=90b656093635, content=肿瘤以外的细胞周期内容接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560739, encodeId=fee1560e39f2, content=请问收不收临床杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/10/4fe36596645bdae9591cdb5eaef8d8ad.jpg, createdBy=d0ff2244072, createdName=医生包子, createdTime=Wed Sep 05 08:42:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560615, encodeId=c0b45606157d, content=你的后来咋样了啊?<span class="quote">fatvicky 2018-08-28 发表::<br>好吧,我的变成decision in process了</span><span class="quote">fatvicky 2018-08-28 00:00:00 发表:<br>好吧,我的变成decision in process了</span>, beContent=fatvicky 2018-08-28 发表:: 好吧,我的变成decision in process了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-26 1227b427m60暂无昵称

    这个接受meta吗

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=562013, encodeId=6b2a56201341, content=我的6号投的,今天还是这贵状态<span class="quote"> 2018-10-12 00:00:00 发表:<br>不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧</span>, beContent= 2018-10-12 00:00:00 发表: 不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RIBJlEmicIauGBQQiaeMgwsS5uz5UatGvaxteNDIUozlgVZFghRIuuUBWSeEy1XCBdEkMK2ic21XuTl6FQGK6C5lg/132, createdBy=e6fc2342780, createdName=mei1996, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561919, encodeId=4b1356191963, content=不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧<span class="quote">maoweipu 2018-10-09 00:00:00 发表:<br>你的什么状态了,我的submitted to journal快一周了</span>, beContent=maoweipu 2018-10-09 00:00:00 发表: 你的什么状态了,我的submitted to journal快一周了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=625f1875342, createdName=ms5567750162973767, createdTime=Fri Oct 12 00:00:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561815, encodeId=43fd561815ea, content=你的什么状态了,我的submitted to journal快一周了<span class="quote">136****6975(暂无匿称) 2018-08-19 发表::<br>今天刚投,submitted to journal.忐忑中。</span><span class="quote">136****6975(暂无匿称) 2018-08-19 00:00:00 发表:<br>今天刚投,submitted to journal.忐忑中。</span>, beContent=136****6975(暂无匿称) 2018-08-19 发表:: 今天刚投,submitted to journal.忐忑中。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Tue Oct 09 00:00:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561606, encodeId=cb585616061a, content=这个杂志是要审稿费吗?<span class="quote">fatvicky 2018-08-21 00:00:00 发表:<br>你的怎么样了?我的under review11天后,现在变成under editor evaluation 了</span>, beContent=fatvicky 2018-08-21 00:00:00 发表: 你的怎么样了?我的under review11天后,现在变成under editor evaluation 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/9781858056D46BD00872513F9FF65E51/100, createdBy=df292075308, createdName=manqing, createdTime=Sun Sep 30 00:00:00 CST 2018, time=2018-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561466, encodeId=80a45614669f, content=这个接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96a82335180, createdName=1227b427m60暂无昵称, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561315, encodeId=ce2d561315ff, content=可以的<span class="quote">135****3848(暂无匿称) 2018-09-11 发表::<br>肿瘤以外的细胞周期内容接受吗</span><span class="quote">135****3848(暂无匿称) 2018-09-11 00:00:00 发表:<br>肿瘤以外的细胞周期内容接受吗</span>, beContent=135****3848(暂无匿称) 2018-09-11 发表:: 肿瘤以外的细胞周期内容接受吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561316, encodeId=1e3a561316ec, content=可以收<span class="quote">医生包子 2018-09-05 发表::<br>请问收不收临床杂志</span><span class="quote">医生包子 2018-09-05 08:42:00 发表:<br>请问收不收临床杂志</span>, beContent=医生包子 2018-09-05 发表:: 请问收不收临床杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560936, encodeId=90b656093635, content=肿瘤以外的细胞周期内容接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560739, encodeId=fee1560e39f2, content=请问收不收临床杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/10/4fe36596645bdae9591cdb5eaef8d8ad.jpg, createdBy=d0ff2244072, createdName=医生包子, createdTime=Wed Sep 05 08:42:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560615, encodeId=c0b45606157d, content=你的后来咋样了啊?<span class="quote">fatvicky 2018-08-28 发表::<br>好吧,我的变成decision in process了</span><span class="quote">fatvicky 2018-08-28 00:00:00 发表:<br>好吧,我的变成decision in process了</span>, beContent=fatvicky 2018-08-28 发表:: 好吧,我的变成decision in process了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-20 tomsyu

    可以的135****3848(暂无匿称) 2018-09-11 发表::
    肿瘤以外的细胞周期内容接受吗
    135****3848(暂无匿称) 2018-09-11 00:00:00 发表:
    肿瘤以外的细胞周期内容接受吗

    135****3848(暂无匿称) 2018-09-11 发表:: 肿瘤以外的细胞周期内容接受吗

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=562013, encodeId=6b2a56201341, content=我的6号投的,今天还是这贵状态<span class="quote"> 2018-10-12 00:00:00 发表:<br>不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧</span>, beContent= 2018-10-12 00:00:00 发表: 不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RIBJlEmicIauGBQQiaeMgwsS5uz5UatGvaxteNDIUozlgVZFghRIuuUBWSeEy1XCBdEkMK2ic21XuTl6FQGK6C5lg/132, createdBy=e6fc2342780, createdName=mei1996, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561919, encodeId=4b1356191963, content=不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧<span class="quote">maoweipu 2018-10-09 00:00:00 发表:<br>你的什么状态了,我的submitted to journal快一周了</span>, beContent=maoweipu 2018-10-09 00:00:00 发表: 你的什么状态了,我的submitted to journal快一周了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=625f1875342, createdName=ms5567750162973767, createdTime=Fri Oct 12 00:00:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561815, encodeId=43fd561815ea, content=你的什么状态了,我的submitted to journal快一周了<span class="quote">136****6975(暂无匿称) 2018-08-19 发表::<br>今天刚投,submitted to journal.忐忑中。</span><span class="quote">136****6975(暂无匿称) 2018-08-19 00:00:00 发表:<br>今天刚投,submitted to journal.忐忑中。</span>, beContent=136****6975(暂无匿称) 2018-08-19 发表:: 今天刚投,submitted to journal.忐忑中。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Tue Oct 09 00:00:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561606, encodeId=cb585616061a, content=这个杂志是要审稿费吗?<span class="quote">fatvicky 2018-08-21 00:00:00 发表:<br>你的怎么样了?我的under review11天后,现在变成under editor evaluation 了</span>, beContent=fatvicky 2018-08-21 00:00:00 发表: 你的怎么样了?我的under review11天后,现在变成under editor evaluation 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/9781858056D46BD00872513F9FF65E51/100, createdBy=df292075308, createdName=manqing, createdTime=Sun Sep 30 00:00:00 CST 2018, time=2018-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561466, encodeId=80a45614669f, content=这个接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96a82335180, createdName=1227b427m60暂无昵称, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561315, encodeId=ce2d561315ff, content=可以的<span class="quote">135****3848(暂无匿称) 2018-09-11 发表::<br>肿瘤以外的细胞周期内容接受吗</span><span class="quote">135****3848(暂无匿称) 2018-09-11 00:00:00 发表:<br>肿瘤以外的细胞周期内容接受吗</span>, beContent=135****3848(暂无匿称) 2018-09-11 发表:: 肿瘤以外的细胞周期内容接受吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561316, encodeId=1e3a561316ec, content=可以收<span class="quote">医生包子 2018-09-05 发表::<br>请问收不收临床杂志</span><span class="quote">医生包子 2018-09-05 08:42:00 发表:<br>请问收不收临床杂志</span>, beContent=医生包子 2018-09-05 发表:: 请问收不收临床杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560936, encodeId=90b656093635, content=肿瘤以外的细胞周期内容接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560739, encodeId=fee1560e39f2, content=请问收不收临床杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/10/4fe36596645bdae9591cdb5eaef8d8ad.jpg, createdBy=d0ff2244072, createdName=医生包子, createdTime=Wed Sep 05 08:42:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560615, encodeId=c0b45606157d, content=你的后来咋样了啊?<span class="quote">fatvicky 2018-08-28 发表::<br>好吧,我的变成decision in process了</span><span class="quote">fatvicky 2018-08-28 00:00:00 发表:<br>好吧,我的变成decision in process了</span>, beContent=fatvicky 2018-08-28 发表:: 好吧,我的变成decision in process了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-20 tomsyu

    可以收医生包子 2018-09-05 发表::
    请问收不收临床杂志
    医生包子 2018-09-05 08:42:00 发表:
    请问收不收临床杂志

    医生包子 2018-09-05 发表:: 请问收不收临床杂志

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=562013, encodeId=6b2a56201341, content=我的6号投的,今天还是这贵状态<span class="quote"> 2018-10-12 00:00:00 发表:<br>不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧</span>, beContent= 2018-10-12 00:00:00 发表: 不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RIBJlEmicIauGBQQiaeMgwsS5uz5UatGvaxteNDIUozlgVZFghRIuuUBWSeEy1XCBdEkMK2ic21XuTl6FQGK6C5lg/132, createdBy=e6fc2342780, createdName=mei1996, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561919, encodeId=4b1356191963, content=不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧<span class="quote">maoweipu 2018-10-09 00:00:00 发表:<br>你的什么状态了,我的submitted to journal快一周了</span>, beContent=maoweipu 2018-10-09 00:00:00 发表: 你的什么状态了,我的submitted to journal快一周了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=625f1875342, createdName=ms5567750162973767, createdTime=Fri Oct 12 00:00:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561815, encodeId=43fd561815ea, content=你的什么状态了,我的submitted to journal快一周了<span class="quote">136****6975(暂无匿称) 2018-08-19 发表::<br>今天刚投,submitted to journal.忐忑中。</span><span class="quote">136****6975(暂无匿称) 2018-08-19 00:00:00 发表:<br>今天刚投,submitted to journal.忐忑中。</span>, beContent=136****6975(暂无匿称) 2018-08-19 发表:: 今天刚投,submitted to journal.忐忑中。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Tue Oct 09 00:00:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561606, encodeId=cb585616061a, content=这个杂志是要审稿费吗?<span class="quote">fatvicky 2018-08-21 00:00:00 发表:<br>你的怎么样了?我的under review11天后,现在变成under editor evaluation 了</span>, beContent=fatvicky 2018-08-21 00:00:00 发表: 你的怎么样了?我的under review11天后,现在变成under editor evaluation 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/9781858056D46BD00872513F9FF65E51/100, createdBy=df292075308, createdName=manqing, createdTime=Sun Sep 30 00:00:00 CST 2018, time=2018-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561466, encodeId=80a45614669f, content=这个接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96a82335180, createdName=1227b427m60暂无昵称, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561315, encodeId=ce2d561315ff, content=可以的<span class="quote">135****3848(暂无匿称) 2018-09-11 发表::<br>肿瘤以外的细胞周期内容接受吗</span><span class="quote">135****3848(暂无匿称) 2018-09-11 00:00:00 发表:<br>肿瘤以外的细胞周期内容接受吗</span>, beContent=135****3848(暂无匿称) 2018-09-11 发表:: 肿瘤以外的细胞周期内容接受吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561316, encodeId=1e3a561316ec, content=可以收<span class="quote">医生包子 2018-09-05 发表::<br>请问收不收临床杂志</span><span class="quote">医生包子 2018-09-05 08:42:00 发表:<br>请问收不收临床杂志</span>, beContent=医生包子 2018-09-05 发表:: 请问收不收临床杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560936, encodeId=90b656093635, content=肿瘤以外的细胞周期内容接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560739, encodeId=fee1560e39f2, content=请问收不收临床杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/10/4fe36596645bdae9591cdb5eaef8d8ad.jpg, createdBy=d0ff2244072, createdName=医生包子, createdTime=Wed Sep 05 08:42:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560615, encodeId=c0b45606157d, content=你的后来咋样了啊?<span class="quote">fatvicky 2018-08-28 发表::<br>好吧,我的变成decision in process了</span><span class="quote">fatvicky 2018-08-28 00:00:00 发表:<br>好吧,我的变成decision in process了</span>, beContent=fatvicky 2018-08-28 发表:: 好吧,我的变成decision in process了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-11 1e1262fam48(暂无匿称)

    肿瘤以外的细胞周期内容接受吗

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=562013, encodeId=6b2a56201341, content=我的6号投的,今天还是这贵状态<span class="quote"> 2018-10-12 00:00:00 发表:<br>不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧</span>, beContent= 2018-10-12 00:00:00 发表: 不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RIBJlEmicIauGBQQiaeMgwsS5uz5UatGvaxteNDIUozlgVZFghRIuuUBWSeEy1XCBdEkMK2ic21XuTl6FQGK6C5lg/132, createdBy=e6fc2342780, createdName=mei1996, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561919, encodeId=4b1356191963, content=不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧<span class="quote">maoweipu 2018-10-09 00:00:00 发表:<br>你的什么状态了,我的submitted to journal快一周了</span>, beContent=maoweipu 2018-10-09 00:00:00 发表: 你的什么状态了,我的submitted to journal快一周了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=625f1875342, createdName=ms5567750162973767, createdTime=Fri Oct 12 00:00:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561815, encodeId=43fd561815ea, content=你的什么状态了,我的submitted to journal快一周了<span class="quote">136****6975(暂无匿称) 2018-08-19 发表::<br>今天刚投,submitted to journal.忐忑中。</span><span class="quote">136****6975(暂无匿称) 2018-08-19 00:00:00 发表:<br>今天刚投,submitted to journal.忐忑中。</span>, beContent=136****6975(暂无匿称) 2018-08-19 发表:: 今天刚投,submitted to journal.忐忑中。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Tue Oct 09 00:00:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561606, encodeId=cb585616061a, content=这个杂志是要审稿费吗?<span class="quote">fatvicky 2018-08-21 00:00:00 发表:<br>你的怎么样了?我的under review11天后,现在变成under editor evaluation 了</span>, beContent=fatvicky 2018-08-21 00:00:00 发表: 你的怎么样了?我的under review11天后,现在变成under editor evaluation 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/9781858056D46BD00872513F9FF65E51/100, createdBy=df292075308, createdName=manqing, createdTime=Sun Sep 30 00:00:00 CST 2018, time=2018-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561466, encodeId=80a45614669f, content=这个接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96a82335180, createdName=1227b427m60暂无昵称, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561315, encodeId=ce2d561315ff, content=可以的<span class="quote">135****3848(暂无匿称) 2018-09-11 发表::<br>肿瘤以外的细胞周期内容接受吗</span><span class="quote">135****3848(暂无匿称) 2018-09-11 00:00:00 发表:<br>肿瘤以外的细胞周期内容接受吗</span>, beContent=135****3848(暂无匿称) 2018-09-11 发表:: 肿瘤以外的细胞周期内容接受吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561316, encodeId=1e3a561316ec, content=可以收<span class="quote">医生包子 2018-09-05 发表::<br>请问收不收临床杂志</span><span class="quote">医生包子 2018-09-05 08:42:00 发表:<br>请问收不收临床杂志</span>, beContent=医生包子 2018-09-05 发表:: 请问收不收临床杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560936, encodeId=90b656093635, content=肿瘤以外的细胞周期内容接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560739, encodeId=fee1560e39f2, content=请问收不收临床杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/10/4fe36596645bdae9591cdb5eaef8d8ad.jpg, createdBy=d0ff2244072, createdName=医生包子, createdTime=Wed Sep 05 08:42:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560615, encodeId=c0b45606157d, content=你的后来咋样了啊?<span class="quote">fatvicky 2018-08-28 发表::<br>好吧,我的变成decision in process了</span><span class="quote">fatvicky 2018-08-28 00:00:00 发表:<br>好吧,我的变成decision in process了</span>, beContent=fatvicky 2018-08-28 发表:: 好吧,我的变成decision in process了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-05 医生包子

    请问收不收临床杂志

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=562013, encodeId=6b2a56201341, content=我的6号投的,今天还是这贵状态<span class="quote"> 2018-10-12 00:00:00 发表:<br>不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧</span>, beContent= 2018-10-12 00:00:00 发表: 不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RIBJlEmicIauGBQQiaeMgwsS5uz5UatGvaxteNDIUozlgVZFghRIuuUBWSeEy1XCBdEkMK2ic21XuTl6FQGK6C5lg/132, createdBy=e6fc2342780, createdName=mei1996, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561919, encodeId=4b1356191963, content=不知道这是什么情况,我的submitted to journal 4天了,大多数杂志一般2天左右就应该with editer了吧<span class="quote">maoweipu 2018-10-09 00:00:00 发表:<br>你的什么状态了,我的submitted to journal快一周了</span>, beContent=maoweipu 2018-10-09 00:00:00 发表: 你的什么状态了,我的submitted to journal快一周了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=625f1875342, createdName=ms5567750162973767, createdTime=Fri Oct 12 00:00:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561815, encodeId=43fd561815ea, content=你的什么状态了,我的submitted to journal快一周了<span class="quote">136****6975(暂无匿称) 2018-08-19 发表::<br>今天刚投,submitted to journal.忐忑中。</span><span class="quote">136****6975(暂无匿称) 2018-08-19 00:00:00 发表:<br>今天刚投,submitted to journal.忐忑中。</span>, beContent=136****6975(暂无匿称) 2018-08-19 发表:: 今天刚投,submitted to journal.忐忑中。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Tue Oct 09 00:00:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561606, encodeId=cb585616061a, content=这个杂志是要审稿费吗?<span class="quote">fatvicky 2018-08-21 00:00:00 发表:<br>你的怎么样了?我的under review11天后,现在变成under editor evaluation 了</span>, beContent=fatvicky 2018-08-21 00:00:00 发表: 你的怎么样了?我的under review11天后,现在变成under editor evaluation 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/9781858056D46BD00872513F9FF65E51/100, createdBy=df292075308, createdName=manqing, createdTime=Sun Sep 30 00:00:00 CST 2018, time=2018-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561466, encodeId=80a45614669f, content=这个接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96a82335180, createdName=1227b427m60暂无昵称, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561315, encodeId=ce2d561315ff, content=可以的<span class="quote">135****3848(暂无匿称) 2018-09-11 发表::<br>肿瘤以外的细胞周期内容接受吗</span><span class="quote">135****3848(暂无匿称) 2018-09-11 00:00:00 发表:<br>肿瘤以外的细胞周期内容接受吗</span>, beContent=135****3848(暂无匿称) 2018-09-11 发表:: 肿瘤以外的细胞周期内容接受吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561316, encodeId=1e3a561316ec, content=可以收<span class="quote">医生包子 2018-09-05 发表::<br>请问收不收临床杂志</span><span class="quote">医生包子 2018-09-05 08:42:00 发表:<br>请问收不收临床杂志</span>, beContent=医生包子 2018-09-05 发表:: 请问收不收临床杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Thu Sep 20 00:00:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560936, encodeId=90b656093635, content=肿瘤以外的细胞周期内容接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560739, encodeId=fee1560e39f2, content=请问收不收临床杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/10/4fe36596645bdae9591cdb5eaef8d8ad.jpg, createdBy=d0ff2244072, createdName=医生包子, createdTime=Wed Sep 05 08:42:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560615, encodeId=c0b45606157d, content=你的后来咋样了啊?<span class="quote">fatvicky 2018-08-28 发表::<br>好吧,我的变成decision in process了</span><span class="quote">fatvicky 2018-08-28 00:00:00 发表:<br>好吧,我的变成decision in process了</span>, beContent=fatvicky 2018-08-28 发表:: 好吧,我的变成decision in process了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-01 tomsyu

    你的后来咋样了啊?fatvicky 2018-08-28 发表::
    好吧,我的变成decision in process了
    fatvicky 2018-08-28 00:00:00 发表:
    好吧,我的变成decision in process了

    fatvicky 2018-08-28 发表:: 好吧,我的变成decision in process了

    0

共500条页码: 35/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分